Diabetic Advocacy Organizations Announce Additional Funding for Research
Zucara Therapeutics, a diabetes-focused life sciences company, has announced additional funding from JDRF to support its Phase 2a study on the effect of its therapeutic, ZT-01, on nocturnal hypoglycemia events…